The inquiry into Utz Brands (NYSE: UTZ) follows the announcement of its sale to Intersnack Group GmbH & Co. KG, which offers shareholders $14.25 per share in cash. Simultaneously, the firm is reviewing the merger between Neuphoria Therapeutics (NASDAQ: NEUP) and Scancell Holdings plc, where stockholders are slated to hold an 11.1% stake in the combined entity.
Investigations also extend to Safety Insurance Group (NASDAQ: SAFT) regarding its acquisition by an affiliate of Mapfre S.A. for $105.00 per share, and the merger involving Northrim Bancorp (NASDAQ: NRIM) and PBCO Financial Corporation. Monteverde & Associates, recognized in the 2025 ISS Securities Class Action Services Report, invites shareholders of these companies to review their legal standing. Interested parties may contact the firm at its Empire State Building headquarters or through their official portal for further information regarding these pending deals.
Comments (0)
No comments yet. Be the first!